147 related articles for article (PubMed ID: 1702898)
1. The response of human B cells to interleukin 4 is determined by their stage of activation and differentiation.
Maher DW; Pike BL; Boyd AW
Scand J Immunol; 1990 Dec; 32(6):631-40. PubMed ID: 1702898
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors.
Fluckiger AC; Rossi JF; Bussel A; Bryon P; Banchereau J; Defrance T
Blood; 1992 Dec; 80(12):3173-81. PubMed ID: 1281692
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 4 strongly augments or inhibits DNA synthesis and differentiation of B-type chronic lymphocytic leukemia cells depending on the co-stimulatory activation and progression signals.
Carlsson M; Sundström C; Bengtsson M; Tötterman TH; Rosén A; Nilsson K
Eur J Immunol; 1989 May; 19(5):913-21. PubMed ID: 2525477
[TBL] [Abstract][Full Text] [Related]
4. Regulatory effects of IL-4 on human B-cell response to IL-2.
Galanaud P; Karray S; Llorente L
Eur Cytokine Netw; 1990; 1(2):57-64. PubMed ID: 2102812
[TBL] [Abstract][Full Text] [Related]
5. Surface immunoglobulin ligands and cytokines differentially affect proliferation and antibody production by human CD5+ and CD5- B lymphocytes.
Nawata Y; Stall AM; Herzenberg LA; Eugui EM; Allison AC
Int Immunol; 1990; 2(7):603-14. PubMed ID: 1703783
[TBL] [Abstract][Full Text] [Related]
6. Proliferative response of highly purified B chronic lymphocytic leukemia cells in serum free culture to interleukin-2 and tumor necrosis factors alpha and beta.
Moberts R; Hoogerbrugge H; van Agthoven T; Löwenberg B; Touw I
Leuk Res; 1989; 13(11):973-80. PubMed ID: 2481793
[TBL] [Abstract][Full Text] [Related]
7. Cellular activation without proliferation to B cell growth factor and interleukin 2 in chronic lymphocytic leukaemia B cells stimulated with phorbol ester plus calcium ionophore.
Engel P; Inglés J; de la Calle O; Gallart T
Clin Exp Immunol; 1989 Apr; 76(1):61-7. PubMed ID: 2500274
[TBL] [Abstract][Full Text] [Related]
8. Role of HLA class I and class II antigens in activation and differentiation of B cells.
Giudizi MG; Biagiotti R; Almerigogna F; Alessi A; Tiri A; Del Prete GF; Ferrone S; Romagnani S
Cell Immunol; 1987 Aug; 108(1):97-108. PubMed ID: 3111726
[TBL] [Abstract][Full Text] [Related]
9. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 4 inhibits the proliferation but not the differentiation of activated human B cells in response to interleukin 2.
Defrance T; Vanbervliet B; Aubry JP; Banchereau J
J Exp Med; 1988 Oct; 168(4):1321-37. PubMed ID: 3262709
[TBL] [Abstract][Full Text] [Related]
11. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
12. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells.
Söderberg O; Christiansen I; Nilsson G; Carlsson M; Nilsson K
Leukemia; 1997 Aug; 11(8):1298-304. PubMed ID: 9264384
[TBL] [Abstract][Full Text] [Related]
14. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
[TBL] [Abstract][Full Text] [Related]
15. Evidence for differential responsiveness of human CD5+ and CD5- B cell subsets to T cell-independent mitogens.
Zupo S; Dono M; Azzoni L; Chiorazzi N; Ferrarini M
Eur J Immunol; 1991 Feb; 21(2):351-9. PubMed ID: 1705511
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells.
Tangye SG; Weston KM; Raison RL
Leuk Lymphoma; 1998 Sep; 31(1-2):121-30. PubMed ID: 9720722
[TBL] [Abstract][Full Text] [Related]
17. Different reactivity of activated human B cells to B-cell growth factor and interleukin 2 in the costimulation assay with anti-IgM antibody and in the preactivation assay with Staphylococcus bacteria.
Almerigogna F; Biagiotti R; Giudizi GM; Del Prete GF; Maggi E; Mazzetti M; Alessi A; Ricci M; Romagnani S
Cell Immunol; 1985 Oct; 95(2):358-67. PubMed ID: 3876163
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody against the human peripheral lymph node homing receptor homologue (Leu 8) inhibits B cell differentiation but not B cell proliferation.
Murakawa Y; Strober W; James SP
J Immunol; 1991 Jan; 146(1):40-6. PubMed ID: 1701799
[TBL] [Abstract][Full Text] [Related]
19. Induction of surface marker changes and monoclonal idiotypic immunoglobulin secretion in lymphoma/leukemia cells: comparative study with interleukin-1, interleukin-2, interleukin-4, 8-bromo-guanosine, pokeweed mitogen, and tetradecanoyl phorbol-13-acetate.
Gazitt Y; Gangavalli A; Thurman GB
Mol Biother; 1989; 1(6):297-304. PubMed ID: 2610949
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligation inhibits IL-2 and SAC+IL-2 induced proliferation in chronic lymphocytic leukaemia cells.
Söderberg O; Christiansen I; Carlsson M; Nilsson K
Scand J Immunol; 1997 Jun; 45(6):706-14. PubMed ID: 9201312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
